- Home
- HCA vs ABT Comparison
HCA vs ABT Comparison
Compare HCA & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HCA | ABT |
|---|---|---|
| Founded | 1968 | 1888 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hospital/Nursing Management | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 105.5B | 152.9B |
| IPO Year | 2009 | 2006 |
Fundamental Metrics
Financial Performance| Metric | HCA | ABT |
|---|---|---|
| Price | $428.04 | $116.50 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 20 | 20 |
| Target Price | ★ $511.84 | $130.90 |
| AVG Volume (30 Days) | 1.3M | ★ 5.9M |
| Earning Date | 04-24-2026 | 04-16-2026 |
| Dividend Yield | 0.72% | ★ 2.76% |
| EPS Growth | ★ 28.77 | N/A |
| EPS | ★ 7.15 | 0.61 |
| Revenue | ★ $75,600,000,000.00 | $44,328,000,000.00 |
| Revenue This Year | $5.11 | $10.75 |
| Revenue Next Year | $4.86 | $8.10 |
| P/E Ratio | ★ $60.03 | $191.20 |
| Revenue Growth | ★ 7.08 | 5.67 |
| 52 Week Low | $353.99 | $81.97 |
| 52 Week High | $556.52 | $137.49 |
Technical Indicators
Market Signals| Indicator | HCA | ABT |
|---|---|---|
| Relative Strength Index (RSI) | 63.58 | 75.76 |
| Support Level | $421.48 | $111.18 |
| Resistance Level | $484.87 | $116.82 |
| Average True Range (ATR) | 11.16 | 2.18 |
| MACD | 1.47 | 0.26 |
| Stochastic Oscillator | 78.78 | 90.79 |
Price Performance
Historical ComparisonAbout HCA HCA Healthcare Inc.
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2025, the firm owned and operated 190 hospitals and over 2,500 outpatient facillities across 19 states and a small foothold in the United Kingdom.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.